TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA
Delisted
TBRA was delisted on the 31st of October, 2016.
68 hedge funds and large institutions have $505M invested in Tobira Therapeutics, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
72% less call options, than puts
Call options by funds: $1.18M | Put options by funds: $4.17M
Holders
68
Holding in Top 10
3
Calls
$1.18M
Puts
$4.17M
Top Buyers
1 | +$147M | |
2 | +$42.5M | |
3 | +$36.6M | |
4 |
BG
Baupost Group
Boston,
Massachusetts
|
+$6.39M |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.33M |
Top Sellers
1 | -$33.9M | |
2 | -$25.5M | |
3 | -$16.3M | |
4 |
A
Abingworth
London,
United Kingdom
|
-$7.38M |
5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$5.88M |